BECHINI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.749
NA - Nord America 6.932
AS - Asia 1.987
OC - Oceania 70
SA - Sud America 36
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.906
PL - Polonia 3.229
IT - Italia 1.589
RU - Federazione Russa 1.340
IE - Irlanda 850
SE - Svezia 735
SG - Singapore 411
CN - Cina 363
HK - Hong Kong 340
IN - India 220
DE - Germania 196
JO - Giordania 176
FI - Finlandia 164
CH - Svizzera 160
TR - Turchia 138
GB - Regno Unito 133
UA - Ucraina 105
KR - Corea 100
VN - Vietnam 66
AU - Australia 65
NL - Olanda 52
FR - Francia 43
ES - Italia 40
TH - Thailandia 36
IR - Iran 33
BR - Brasile 23
PH - Filippine 20
CA - Canada 19
BE - Belgio 16
CZ - Repubblica Ceca 16
ID - Indonesia 16
GR - Grecia 14
TW - Taiwan 13
BG - Bulgaria 11
AT - Austria 10
JP - Giappone 10
LV - Lettonia 10
AR - Argentina 9
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
HR - Croazia 6
SI - Slovenia 6
BH - Bahrain 5
KZ - Kazakistan 5
MX - Messico 5
MY - Malesia 5
PK - Pakistan 5
ZA - Sudafrica 5
CY - Cipro 4
EG - Egitto 4
SA - Arabia Saudita 4
SC - Seychelles 4
FJ - Figi 3
IL - Israele 3
NO - Norvegia 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
CL - Cile 2
EU - Europa 2
HU - Ungheria 2
IS - Islanda 2
KE - Kenya 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AL - Albania 1
AN - Antille olandesi 1
BD - Bangladesh 1
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
HN - Honduras 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
PE - Perù 1
TJ - Tagikistan 1
Totale 17.794
Salva come PNG Salva come JPEG
Città #
Warsaw 3.215
Fairfield 862
Dublin 845
Chandler 724
Ashburn 448
Cambridge 371
Seattle 358
Woodbridge 350
Singapore 311
Houston 302
Florence 285
Wilmington 281
Princeton 239
Lawrence 210
Altamura 206
Mumbai 191
Jacksonville 180
Beijing 176
Boston 175
Buffalo 171
Ann Arbor 153
Bern 151
Hong Kong 149
Boardman 143
New York 97
Medford 95
Shanghai 89
Moscow 88
San Diego 75
Izmir 71
Kent 69
Rome 59
Dong Ket 56
Milan 55
Santa Clara 55
Los Angeles 50
Sydney 42
Bremen 41
Norwalk 41
Dearborn 36
London 29
Hillsboro 28
Bangkok 25
Falls Church 23
Andover 21
Barcelona 20
Seodaemun-gu 20
Genoa 19
Phoenix 18
Seoul 16
Toronto 16
Gangnam-gu 15
Helsinki 15
Naples 15
Catania 14
Melbourne 14
Plymouth 14
West Jordan 14
Amsterdam 13
Bologna 13
Pune 13
Redwood City 13
Padova 12
Roelofarendsveen 12
Ancona 11
Bari 11
Brussels 11
Palermo 11
Brno 10
Goyang-si 10
Philadelphia 10
Riga 10
Rimini 10
Auburn Hills 9
Bergamo 9
Guangzhou 9
Napoli 9
Perugia 9
Pisa 9
Turin 9
Baltimore 8
Brescia 8
Genova 8
Olgiate Olona 8
Parma 8
Boadilla del Monte 7
Chiang Mai 7
Laurel 7
Prato 7
Sassari 7
Sofia 7
Washington 7
Anguillara Sabazia 6
Dubai 6
Hamburg 6
Livorno 6
Makati City 6
Manchester 6
Mendiolaza 6
Nanjing 6
Totale 12.221
Salva come PNG Salva come JPEG
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 755
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 390
HPV vaccination for boys? A systematic review of economic studies 259
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 238
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 238
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 232
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 229
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 218
Human papilloma virus vaccination: impact and recommendations across the world. 217
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 214
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 211
The epidemiology of mumps in Italy 204
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 204
The epidemiology of Varicella Zoster Virus infection in Italy. 203
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 199
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 197
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 190
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 186
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 175
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 171
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 165
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 158
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 157
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 155
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries 144
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 141
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 137
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 137
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 135
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 126
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 124
INCREASING RESISTANCE IN COMMENSAL ESCHERICHIA COLI, BOLIVIA AND PERU 122
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 121
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 118
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 111
Progress in Italy in control and elimination of measles and congenital rubella. 109
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 104
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 104
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 103
Recommended vaccinations for asplenic and hyposplenic adult patients 102
Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project 97
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 96
Progress in Italy in control and elimination of measles and congenital rubella. 95
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 93
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 91
Health literacy and vaccination: A systematic review 90
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 90
Focusing on the implementation of 21st century vaccines for adults 90
An overview on the implementation of HPV vaccination in Europe. 88
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. 87
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 87
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 87
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence 86
Measurement and reporting of burden of disease for hepatitis a: results of the EUROHEP.NET feasibility survey 85
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 85
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 82
The expected impact of new vaccines and vaccination policies. 81
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 81
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 81
Awareness of hepatitis B and C screening and patient management guidelines among health professionals in six European countries 80
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 80
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 80
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 80
Valutazione dell’immunità umorale e cellulo-mediata verso Bordetella pertussis in Toscana 79
Immunization with the 7-valent conjugate pneumococcal vaccine: Impact evaluation, continuing surveillance and future perspectives. 77
Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B 76
Assessment of the clinical and economic impact of different immunization protocols of measles, mumps, rubella and varicella in internationally adopted children 75
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 75
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 74
Clinical and economic impact of herpes zoster vaccination in elderly in Italy 74
Gli operatori sanitari degli ospedali fiorentini: protetti o non protetti verso morbillo, parotite, rosolia e varicella? 74
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 73
Safety and tolerability of bivalent HPV vaccine: An Italian post-licensure study. 73
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 73
Hepatitis B: Are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries 72
Measles outbreak in Grosseto, central Italy, 2006. 72
Un caso di studio su una sospetta associazione tra vaccinazione anti-varicella e reazione avversa a vaccino. 72
Evaluating the costs and benefits of pneumococcal vaccination in adults 72
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 70
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 70
An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign 69
A cost-benefit analysis of different varicella vaccination strategies involving italian children and adolescents. 69
The burden of disease of Herpes Zoster in Tuscany 68
Analisi economica della vaccinazione anti-varicella nei bambini e negli adolescenti italiani: il peso delle ospedalizzazioni senza complicazioni. 66
Immunization status against measles, mumps, rubella and varicella in a large population of internationally adopted children referred to Meyer children’s university hospital from 2009 to 2018 66
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 65
Stesura di linee guida per i piani pandemici aziendali della Regione Toscana 65
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 65
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 64
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 64
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 63
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 63
Progress in the elimination of measles and congenital rubella in Central Italy. 63
Epatite B e C: pratiche di counselling e referral in soggetti migranti (progetto HEPSCREEN) 63
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 62
Towards measles elimination in Italy: Monitoring herd immunity by Bayesian mixture modelling of serological data 62
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 61
Discrepancies between Protocols of Immunization Targeting Internationally Adopted Children in Western Countries 61
L’efficacia del vaccino anti-HPV 60
Economic studies applied to vaccines against invasive diseases: An updated budget impact analysis of age-based pneumococcal vaccination strategies in the elderly in Italy 59
Totale 12.024
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.244 0 0 110 203 290 270 230 313 223 270 280 55
2020/20211.932 158 195 80 201 110 234 96 148 176 308 77 149
2021/20221.452 55 180 82 54 38 38 47 128 40 59 270 461
2022/20234.050 344 616 219 259 250 706 543 235 529 28 134 187
2023/20242.545 88 201 296 177 227 292 195 340 109 228 222 170
2024/20252.273 467 1.277 529 0 0 0 0 0 0 0 0 0
Totale 18.049